Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma.

Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, Raffeld M, Cafaro A, Chang HK, Brady JN, Gallo RC.

Nature. 1994 Oct 20;371(6499):674-80.

PMID:
7935812
2.

Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2.

Albini A, Fontanini G, Masiello L, Tacchetti C, Bigini D, Luzzi P, Noonan DM, Stetler-Stevenson WG.

AIDS. 1994 Sep;8(9):1237-44.

PMID:
7528513
3.

Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor.

Toschi E, Barillari G, Sgadari C, Bacigalupo I, Cereseto A, Carlei D, Palladino C, Zietz C, Leone P, Stürzl M, Buttò S, Cafaro A, Monini P, Ensoli B.

Mol Biol Cell. 2001 Oct;12(10):2934-46.

5.

Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin.

Barillari G, Sgadari C, Palladino C, Gendelman R, Caputo A, Morris CB, Nair BC, Markham P, Nel A, Stürzl M, Ensoli B.

J Immunol. 1999 Aug 15;163(4):1929-35.

6.
7.
8.
9.

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients.

Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F.

Nature. 1990 May 3;345(6270):84-6.

PMID:
2184372
10.

Human Kaposi's sarcoma cell-mediated tumorigenesis in human immunodeficiency type 1 tat-expressing transgenic mice.

Prakash O, Tang ZY, He YE, Ali MS, Coleman R, Gill J, Farr G, Samaniego F.

J Natl Cancer Inst. 2000 May 3;92(9):721-8.

PMID:
10793108
11.
12.

Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.

Morini M, Benelli R, Giunciuglio D, Carlone S, Arena G, Noonan DM, Albini A.

Biochem Biophys Res Commun. 2000 Jun 24;273(1):267-71.

PMID:
10873597
13.

The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor.

Barillari G, Sgadari C, Fiorelli V, Samaniego F, Colombini S, Manzari V, Modesti A, Nair BC, Cafaro A, Stürzl M, Ensoli B.

Blood. 1999 Jul 15;94(2):663-72.

14.
16.

Pathogenesis of AIDS-associated Kaposi's sarcoma.

Ensoli B, Barillari G, Gallo RC.

Hematol Oncol Clin North Am. 1991 Apr;5(2):281-95. Review.

PMID:
2022594
17.

Spindle cells from AIDS-associated Kaposi's sarcoma lesions express telomerase activity that is enhanced by Kaposi's sarcoma progression factors.

Barillari G, Franzese O, Comandini A, Bonmassar E, Ensoli B.

Oncol Rep. 2010 Jul;24(1):219-23.

PMID:
20514465
18.

The HIV-1 TAT protein induces the expression and extracellular appearance of acidic fibroblast growth factor.

Opalenik SR, Shin JT, Wehby JN, Mahesh VK, Thompson JA.

J Biol Chem. 1995 Jul 21;270(29):17457-67.

19.

Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.

Samaniego F, Markham PD, Gendelman R, Watanabe Y, Kao V, Kowalski K, Sonnabend JA, Pintus A, Gallo RC, Ensoli B.

Am J Pathol. 1998 Jun;152(6):1433-43.

20.

Signalling properties of an HIV-encoded angiogenic peptide mimicking vascular endothelial growth factor activity.

Scheidegger P, Weiglhofer W, Suarez S, Console S, Waltenberger J, Pepper MS, Jaussi R, Ballmer-Hofer K.

Biochem J. 2001 Feb 1;353(Pt 3):569-78.

Supplemental Content

Support Center